Citation Impact
Citing Papers
Nucleofection of Expression Vectors Induces a Robust Interferon Response and Inhibition of Cell Proliferation
2013
Review on plant antimicrobials: a mechanistic viewpoint
2019 Standout
Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
2021 Standout
Editing the epigenome: technologies for programmable transcription and epigenetic modulation
2016
Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
2019
Macrophages in immunoregulation and therapeutics
2023 Standout
Resveratrol mediates cell cycle arrest and cell death in human esophageal squamous cell carcinoma by directly targeting the EGFR signaling pathway
2016
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Targeted DNA demethylation in vivo using dCas9–peptide repeat and scFv–TET1 catalytic domain fusions
2016
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
Resveratrol, human health and winemaking perspectives
2017
Targeting Toll-like receptors against cancer
2016
Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases
2015
Polyphenols and Human Health: The Role of Bioavailability
2021 Standout
Toll-like Receptors from the Perspective of Cancer Treatment
2020
Works of Jinming Di being referenced
Inhibition of WEE1 Suppresses the Tumor Growth in Laryngeal Squamous Cell Carcinoma
2018
Toll-like receptor 9 agonists promote IL-8 and TGF-β1production via activation of nuclear factor κB in PC-3 cells
2009
Resveratrol Oligomers for the Prevention and Treatment of Cancers
2014
Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer
2015
Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing.
2016
Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase
2015